Intuitive Surgical Boosts Q4 Revenue Guidance Amid Growth Concerns

Intuitive Surgical has raised its Q4 revenue guidance to $2.866 billion, up from $2.72 billion. Despite this, the stock is trading lower due to concerns over a slowdown in growth. The company expects year-over-year revenue growth of 18.8% and worldwide procedure growth of 18%. However, growth in Ion procedures and system placements remains strong, with 532 da Vinci surgical systems and 303 da Vinci 5 systems placed in Q4.